|
Predisposing conditions
|
European (n=122)
|
Maori (n=47)
|
Pacific (n=60)
|
Others (n=17)
|
Total (n=247)
|
p-value
|
|---|
| |
No.
|
%
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
No.
|
%
| |
|---|
|
Diabetes mellitus
|
28
|
23.0
|
14
|
29.8
|
27
|
45.0
|
10
|
58.8
|
79
|
32.0
|
0.002
|
|
Alcohol abuse
|
11
|
9.0
|
3
|
6.4
|
0
|
0.0
|
1
|
5.9
|
15
|
6.1
|
0.126
|
|
Obesity
|
23
|
18.9
|
16
|
34.0
|
14
|
23.3
|
3
|
17.6
|
56
|
22.7
|
0.193
|
|
Coronary heart disease
|
22
|
18.0
|
8
|
17.0
|
5
|
8.3
|
5
|
29.4
|
40
|
16.2
|
0.156
|
|
Congestive heart failure
|
15
|
12.3
|
6
|
12.8
|
10
|
16.7
|
2
|
11.8
|
33
|
13.4
|
0.865
|
|
Peripheral vascular disease
|
14
|
11.5
|
6
|
12.8
|
4
|
6.7
|
2
|
11.8
|
26
|
10.5
|
0.720
|
|
Chronic obstructive
|
16
|
13.1
|
4
|
8.5
|
2
|
3.3
|
0
|
0.0
|
22
|
8.9
|
0.086
|
|
pulmonary disease
| | | | | | | | | | | |
|
Cancer
|
12
|
9.8
|
3
|
6.4
|
1
|
1.7
|
2
|
11.8
|
18
|
7.3
|
0.210
|
|
Chronic renal failure
|
11
|
9.0
|
9
|
19.1
|
7
|
11.7
|
2
|
11.8
|
29
|
11.7
|
0.341
|
|
Steroid use
|
14
|
11.5
|
2
|
4.3
|
1
|
1.7
|
0
|
0.0
|
17
|
6.9
|
0.040
|
|
Non-steroidal anti-inflammatory drug use*
|
29
|
23.8
|
11
|
23.4
|
10
|
16.7
|
7
|
41.2
|
57
|
23.1
|
0.208
|
|
No condition documented
|
18
|
14.8
|
10
|
21.3
|
20
|
33.3
|
0
|
0.0
|
49
|
19.8
|
0.004
|
- *Low-dose Aspirin 100mg/day or less excluded.
